Talaris Therapeutics, Inc. License Agreements
3 Contracts & Agreements
- License Agreement by and between Tourmaline Bio, LLC and Lonza Sales AG, dated May 16, 2022 (Filed With SEC on July 20, 2023)
- License Agreement by and between Tourmaline Bio, LLC and Pfizer Inc., dated May 3, 2022 (Filed With SEC on July 20, 2023)
- Amended and Restated Exclusive License Agreement, by and between the Registrant and University of Louisville Research Foundation, Inc., dated October 31, 2018 (Filed With SEC on April 16, 2021)
